1. Home
  2. EDSA vs TAIT Comparison

EDSA vs TAIT Comparison

Compare EDSA & TAIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • TAIT
  • Stock Information
  • Founded
  • EDSA 2015
  • TAIT 1989
  • Country
  • EDSA Canada
  • TAIT United States
  • Employees
  • EDSA N/A
  • TAIT N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • TAIT Electronic Components
  • Sector
  • EDSA Health Care
  • TAIT Technology
  • Exchange
  • EDSA Nasdaq
  • TAIT Nasdaq
  • Market Cap
  • EDSA 13.8M
  • TAIT 13.3M
  • IPO Year
  • EDSA N/A
  • TAIT 1995
  • Fundamental
  • Price
  • EDSA $2.05
  • TAIT $2.18
  • Analyst Decision
  • EDSA Strong Buy
  • TAIT
  • Analyst Count
  • EDSA 2
  • TAIT 0
  • Target Price
  • EDSA $13.00
  • TAIT N/A
  • AVG Volume (30 Days)
  • EDSA 33.4K
  • TAIT 16.6K
  • Earning Date
  • EDSA 08-08-2025
  • TAIT 08-13-2025
  • Dividend Yield
  • EDSA N/A
  • TAIT 9.21%
  • EPS Growth
  • EDSA N/A
  • TAIT N/A
  • EPS
  • EDSA N/A
  • TAIT 0.01
  • Revenue
  • EDSA N/A
  • TAIT $4,260,000.00
  • Revenue This Year
  • EDSA N/A
  • TAIT N/A
  • Revenue Next Year
  • EDSA N/A
  • TAIT N/A
  • P/E Ratio
  • EDSA N/A
  • TAIT $225.79
  • Revenue Growth
  • EDSA N/A
  • TAIT N/A
  • 52 Week Low
  • EDSA $1.55
  • TAIT $2.01
  • 52 Week High
  • EDSA $5.59
  • TAIT $3.05
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 52.89
  • TAIT 47.75
  • Support Level
  • EDSA $1.91
  • TAIT $2.15
  • Resistance Level
  • EDSA $2.14
  • TAIT $2.28
  • Average True Range (ATR)
  • EDSA 0.12
  • TAIT 0.07
  • MACD
  • EDSA 0.02
  • TAIT 0.00
  • Stochastic Oscillator
  • EDSA 64.52
  • TAIT 28.00

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About TAIT Taitron Components Incorporated

Taitron Components Inc is a supplier of originally designed and manufactured (ODM) products that include value-added engineering and turn-key solutions. It focuses on providing original equipment manufacturers (OEMs) and contracts electronic manufacturers (CEMs) with ODM products for their multi-year turn-key projects and ODM electronic components. The company's product offerings range from discrete semiconductors to small electronic devices. The company also distributes brand-name electronic components with a vast inventory available on hand. Its Taiwan and China locations, provide support for inventory sourcing, purchases, and coordinating the manufacture of ODM Projects and ODM Components.

Share on Social Networks: